Roopa Industries

Roopa Industries Operating Cash Flow

The Operating Cash Flow of Roopa Industries (530991.BO) as of Nov 4, 2026 is 46.76 M INR. In the previous year, Operating Cash Flow was -65.94 M INR — a change of -170.92% (higher).

Operating Cash Flow

46.76 MINR

YoY

-170.92%

Last updated:

Operating Cash Flow of Roopa Industries is 2026 46.76 M INR. Operating Cash Flow of Roopa Industries was 2025 -65.94 M INR. It decreases by -170.92% higher compared to the previous year.

The Roopa Industries Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2019
44.18 M INR
Jan 1, 2020
24.44 M INR
Jan 1, 2021
-5.15 M INR
Jan 1, 2022
23.44 M INR
Jan 1, 2023
89.11 M INR
Jan 1, 2024
-32.85 M INR
Jan 1, 2025
-65.94 M INR
Jan 1, 2026
46.76 M INR
The Roopa Industries Operating Cash Flow history
YEAROperating Cash FlowYoY
46.76 MINR-170.92%
-65.94 MINR+100.74%
-32.85 MINR-136.86%
89.11 MINR+280.11%
23.44 MINR-555.13%
-5.15 MINR-121.08%
24.44 MINR-44.68%
44.18 MINR-197.48%
-45.32 MINR+165.22%
-17.09 MINR-234.30%
12.72 MINR+111.90%
6.00 MINR-8.69%
6.58 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Roopa Industries Stock analysis

What does Roopa Industries do? Roopa Industries Ltd. manufactures pharmaceutical products, focusing on bulk drugs and drug intermediates. The company produces N,N-dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is used by manufacturers of Cephalosporin antibiotics and Statins, while Bromine And Its Derivatives serve agrochemicals, dyes, medical and veterinary products, water purification, and pesticides. Glucosamine is a key nutraceutical product. The primary buyers include pharmaceutical manufacturers, agrochemical companies, and producers of medical and veterinary compounds. The company's revenue streams come from the sale of these specialized chemical products to industries requiring bulk drugs and intermediates. Triphenyl Phosphine supports antibiotic and statin production, making it essential for pharmaceutical firms. Bromine And Its Derivatives cater to diverse sectors like agriculture, water treatment, and disinfection, with significant demand from agrochemical and medical product manufacturers. Glucosamine, as a sheet anchor product, drives sales in the nutraceutical market. Roopa Industries targets the pharmaceutical, agrochemical, and medical sectors with its product portfolio. The firm's focus on bulk drugs and intermediates positions it as a supplier to manufacturers of antibiotics, statins, and nutraceuticals. Its products are integral to the production of Cephalosporin group antibiotics, Statins, and various agrochemical applications, ensuring consistent demand from established industrial buyers. Roopa Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Roopa Industries stock

Operating Cash Flow of Roopa Industries is 46.76 M INR in 2026.

Operating Cash Flow of Roopa Industries changed from -65.94 M INR to 46.76 M INR, representing a -170.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Roopa Industries since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Roopa Industries historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Roopa Industries

All Key Metrics — Roopa Industries